Efficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with ACTN4

Abstract

Although several clinical trials have demonstrated the benefits of platinum-combined adjuvant chemotherapy for resected non-small cell lung cancer (NSCLC), predictive biomarkers for the efficacy of such therapy have not yet been identified. Selection of patients with high metastatic ability in the early stage of non-small cell lung cancer (NSCLC) has the… (More)
DOI: 10.18632/oncotarget.8890

Topics

9 Figures and Tables

Cite this paper

@inproceedings{Miura2016EfficacyOA, title={Efficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with ACTN4}, author={Nami Miura and Masahiro Kamita and Takanori Kakuya and Yutaka Fujiwara and Koji Tsuta and Hideaki Shiraishi and Fumitaka Takeshita and Takahiro Ochiya and Hirokazu Shoji and W. X. Huang and Yuichiro Ohe and Tesshi Yamada and Kazufumi Honda}, booktitle={Oncotarget}, year={2016} }